UROGEN PHARMA LTD (URGN) Stock Cash Flow
NASDAQ:URGN - Nasdaq - IL0011407140 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -138.43M | -126.87M | -102.24M | -109.78M | -110.82M | |||
| Depreciation Amortization | 703.00K | 329.00K | 802.00K | 920.00K | 830.00K | |||
| Change In Working Capital | 6.31M | 4.88M | 3.34M | -6.31M | -14.28M | |||
| Other non cash items | 24.36M | 24.89M | 21.73M | 27.61M | 39.38M | |||
| OPERATING CASH FLOW | -107.06M | -96.77M | -76.38M | -87.56M | -84.89M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -339.00K | -295.00K | -194.00K | -250.00K | -750.00K | |||
| Other Investing Activity | -59.76M | -20.32M | -759.00K | 1.31M | 4.82M | |||
| INVESTING CASH FLOW | -60.09M | -20.61M | -953.00K | 1.06M | 4.07M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 24.49M | 0.00 | 95.78M | N/A | |||
| Stock Issued/Repurchased | 115.51M | 170.13M | 116.93M | 1.51M | 60.00K | |||
| Other Financing Activity | N/A | N/A | 0.00 | -160.00K | 72.26M | |||
| FINANCING CASH FLOW | 140.00M | 194.62M | 116.93M | 97.13M | 72.32M | |||
| CHANGE IN CASH | -27.15M | 77.24M | 39.60M | 10.63M | -8.50M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -107.06M | -96.77M | -76.38M | -87.56M | -84.89M | |||
| Capital Expenditure | -339.00K | -295.00K | -194.00K | -250.00K | -750.00K | |||
| FREE CASH FLOW | -107.39M | -97.06M | -76.57M | -87.81M | -85.64M | |||
All data in USD